Records 1 - 30
| Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial.
Lung cancer (Amsterdam, Netherlands) 2022 Jul 169 67-76.
Soo Ross A, Huat Tan Eng, Hayashi Hidetoshi, Seto Takashi, Lin Chia-Chi, Ignatius Ou Sai-Hong, Kim Dong-Wan, Liu Geoffrey, Abbattista Antonello, Martini Jean-François, Hooi Wong Chew, Toffalorio Francesca, Solomon Benjamin
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib.
BMC medical genomics 2022 Jun 15 (1): 141.
Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X
| Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
JAMA network open 2022 Jun 5 (6): e2215589.
Liu Yufei, Zhang Zhe, Rinsurongkawong Waree, Gay Carl M, Le Xiuning, Ning Matthew S, Lewis Jeff, Rinsurongkawong Vadeerat, Lee J Jack, Roth Jack, Swisher Stephen, Gandhi Saumil, Lee Percy P, Gibbons Don L, Vaporciyan Ara A, Heymach John V, Zhang Jianjun, Lin Steven
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer 2022 Jun .
Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam
| An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer.
BMC pulmonary medicine 2022 May 22 (1): 209.
Wang Shuai, Shou Huankai, Wen Haoyu, Wang Xingxing, Wang Haixing, Lu Chunlai, Gu Jie, Xu Fengkai, Zhu Qiaoliang, Wang Lin, Ge
| Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
The oncologist 2022 May .
Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
BMC cancer 2022 May 22 (1): 580.
Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic
| Genomic features of Chinese small cell lung cancer.
BMC medical genomics 2022 May 15 (1): 117.
Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw
| First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
International journal of clinical oncology 2022 Feb .
John Thomas, Sakai Hiroshi, Ikeda Satoshi, Cheng Ying, Kasahara Kazuo, Sato Yuki, Nakahara Yoshiro, Takeda Masayuki, Kaneda Hiroyasu, Zhang Helong, Maemondo Makoto, Minato Koichi, Hisada Takeshi, Misumi Yuki, Satouchi Miyako, Hotta Katsuyuki, Li Ang, Oukessou Abderrahim, Lu Sh
| Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance.
Lung cancer (Amsterdam, Netherlands) 2022 Feb 166 63-69.
Sun Ke, Li Meiling, Shang Mingdong, Su Xiaolian, Zhao Jiabi, Wang Bin, Wu Chunyan, Zhang Lei, Yang Shan, Sun Xiw
| ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061).
Lung cancer (Amsterdam, Netherlands) 2022 Jan 165 54-62.
Li Meichen, Hou Xue, Chen Jing, Zhang Baishen, Wang Na, Han Hongyu, Chen Lik
| Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.
The clinical respiratory journal 2022 Jan .
Liu Qinghua, Huang Qingyan, Yu Zhikang, Wu Hemi
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma.
Pathology, research and practice 2022 Jan 231 153761.
Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer.
Frontiers in medicine 2022 9 808378.
Peng Jie, Xiao Lushan, Zou Dan, Han Lij
| Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics.
PloS one 2022 17 (1): e0262822.
Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa
| Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers.
Journal of bone oncology 2021 Dec 31 100394.
Meng Chunliu, Wei Jia, Tian Jia, Ma Jintao, Liu Ningbo, Yuan Zhiyong, Zhao Lujun, Wang Pi
| Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Cureus 2021 Dec 13 (12): e20398.
Matsunaga Shigeo, Shuto Takas
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort.
Clinical lung cancer 2021 Aug .
Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions.
Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 66-73.
Mondaca Sebastian, Lebow Emily S, Namakydoust Azadeh, Razavi Pedram, Reis-Filho Jorge S, Shen Ronglai, Offin Michael, Tu Hai-Yan, Murciano-Goroff Yonina, Xu Chongrui, Makhnin Alex, Martinez Andres, Pavlakis Nick, Clarke Stephen, Itchins Malinda, Lee Adrian, Rimner Andreas, Gomez Daniel, Rocco Gaetano, Chaft Jamie E, Riely Gregory J, Rudin Charles M, Jones David R, Li Mark, Shaffer Tristan, Hosseini Seyed Ali, Bertucci Caterina, Lim Lee P, Drilon Alexander, Berger Michael F, Benayed Ryma, Arcila Maria E, Isbell James M, Li Bob
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Pathology, research and practice 2021 Jul 224 153551.
Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases.
Clinical neurology and neurosurgery 2021 Jul 208 106841.
Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi
| One-step polymerase chain reaction-free nanowire-based plasma cell-free DNA assay to detect EML4-ALK fusion and to monitor resistance in lung cancer.
The oncologist 2021 Jul .
Lee Youngjoo, Cho Youngnam, Park Eun Young, Park Seong-Yun, Hwang Kum Hui, Han Ji-Yo
| Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.
Cancer treatment and research communications 2021 Jul 28 100440.
Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients.
Asian journal of surgery 2021 Jul .
Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij
| Validation of the Novel IASLC Grading System for Invasive Pulmonary Adenocarcinoma and Association with Common Driver Mutations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Jul .
Deng Chaoqiang, Zheng Qiang, Zhang Yang, Jin Yan, Shen Xuxia, Nie Xiao, Fu Fangqiu, Ma Xiangyi, Ma Zelin, Wen Zhexu, Wang Shengping, Li Yuan, Chen Haiqu
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces.
Annals of translational medicine 2021 Jun 9 (12): 985.
Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Molecular oncology 2021 May .
Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc
| Molecular characterization of lung carcinomas: A study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India.
Journal of carcinogenesis 2021 20 17.
Rao Shalinee, Anthony Michael Leonard, Chowdhury Nilotpal, Kathrotia Rajesh, Mishra Mayank, Naithani Manisha, Sindhwani Girish, Singh Ne
| Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma.
OncoTargets and therapy 2021 14 2953-2965.
Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caic
| A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution.
Lung India : official organ of Indian Chest Society 0 39 (4): 315-318.
Roy Mohana, Bal Amanjit, Gupta Nalini, Prasad Kuruswamy T, Wakelee Heather A, Singh Navne